Brensocatib to be studied in patients with severe covid-19 in investigator-initiated trial

Brensocatib (formerly ins1007) to be studied in patients with severe covid-19 in investigator-initiated trial.insmed inc - insmed to support stop-covid19 study, expected to begin in uk in may 2020.insmed inc - stop-covid19 trial is a prospective, randomized, double-blind, placebo-controlled trial of brensocatib in patients with severe covid-19.insmed inc - will continue to develop brensocatib in patients with bronchiectasis.
INSM Ratings Summary
INSM Quant Ranking